Antibody-drug conjugates in lung cancer: scientific breakthroughs and future directions in clinical trials
Int J Surg
.
2025 Jun 12.
doi: 10.1097/JS9.0000000000002718.
Online ahead of print.
Authors
Qing-Dong Zhu
1
,
Chang Song
1
2
,
Chun-Yan Zhao
1
2
,
Hang-Biao Qiang
1
,
Ren-Hao Liu
2
,
Chun-Ming Gong
1
,
Qiu-Qing Tan
1
,
Chang-Yue Jiang
3
,
Mei Yu
4
Affiliations
1
Department of Tuberculosis, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
2
Guangxi Medical University, Nanning, Guangxi, China.
3
Department of Pharmacy, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
4
Department of Anesthesiology, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
PMID:
40503774
DOI:
10.1097/JS9.0000000000002718
No abstract available